MTIP is the largest Pan-European growth equity investor purely focused on the healthtech sector, supporting companies that revolutionize global healthcare whilst generating top quartile returns to our investors. We invest in the most innovative healthtech companies that bring efficiency on healthcare accessibility, affordability, availability as well as quality. Our purpose is to empower innovation that improves lives by accelerating the adoption of digital technologies in healthcare.
We do this across digital health products, tech-enabled healthcare services as well as connected medical devices. As a leading impact investor, we actively engage with our companies on ESG topics, and believe social responsibility is critical for long-term and sustainable value creation. Thus, we are proud to be SFDR Art.9 compliant as of MTIP Fund II characterized as one of the first “dark green“ funds with our products targeting sustainable investments.
Largest and most experienced European Healthtech Growth Equity Investor: We contribute to a more sustainable and equitable world through our investments and actions.
As an impact investor, we are proud of our strong commitment to social responsibility that supports long-term and sustainable value creation providing capital to tackle inequality in access to quality healthcare.
We have developed a strong deal flow across all our core markets and have gained access to the most attractive healthtech investments.
Our deep specialization in healthtech creates a strong network effect across investment cycle.
We have a unique skill set within our investment team, consisting of specialists in healthcare, finance and software.
We create value through the team’s unique combination of sector and operational expertise for a successful exit.
We have a global network of sophisticated financial and strategic partners and advisors at our disposal.
As an impact-driven investor with social investment objective, our portfolio companies contribute to the achievement of Sustainable Development Goals.
We focus primarily on Europe including Switzerland, UK and Israel.
As healthtech investors, we cover digital health, tech-enabled healthcare services and connected medical devices.
We target equity investment of up to €50m per company throughout all financing rounds and minimum €10m as an initial investment.
We act as lead investors (selectively co-lead) and we seek to own significant minority equity stake in the businesses we invest in. As an active investor, we typically take a board position and engage with the executive team as “sparring partners“, advisors and a sounding board to accelerate growth.
We target growth stage companies with EUR 5m+ revenues and proven product-market fit with clear pathway to profitability (or profitable) during our investment period.
We invest in businesses with B2B characteristics, recurring or re-occurring revenue streams and scalable business models with significant growth opportunities within the investment period and clear focus on long-term value creation.
We hold investments 3-7 years and exit through sale to strategic, investor or IPO.
TrailBlazer is transforming MTIP’s investment decision-making process by utilizing cutting-edge workflow automation technology, providing MTIP with a competitive advantage and a fresh approach to digital thinking.
Led by MTIP’s data science team, TrailBlazer started in 2021 with its mission to refine MTIP’s differentiated growth investment approach. The platform is built on continuously growing data sources and can be used to identify the most promising investments for successful growth and value creation while mitigating risks.
TrailBlazer can improve the investment decision-making process and mitigate risk in several ways:
Deal Sourcing: MTIP combines its in-depth digital health market knowledge with automation capabilities to automatically identify opportunities from the most relevant data sources.
Deal Screening: TrailBlazer will be analyzing existing and new investment opportunities by applying MTIP's investment criteria to the latest company metrics, working hand in hand with investment professionals to identify fits as soon as possible.
Deal Execution: Before MTIP takes an investment decision, TrailBlazer helps benchmark the investee to peers, identifies competitors, and supports the dedal team in identifying and analyzing associated risks.
Portfolio Management & Monitoring: TrailBlazer analyzes operational data and benchmarks the KPIs from MTIP's portfolio companies against each other, as well as against the market.